Carlson E R, Catone G A
Division of Oral and Maxillofacial Surgery, Allegheny General Hospital, Pittsburgh, Pa.
Oral Surg Oral Med Oral Pathol. 1988 Apr;65(4):404-5. doi: 10.1016/0030-4220(88)90352-0.
The lupus anticoagulant is a unique inhibitor of hemostasis. Its occurrence in patients with systemic lupus erythematosus reportedly varies from 5% to 50%. The inhibitor is endogenously produced and occurs in a diverse number of clinical states. The present case report reviews an inadvertent discovery of circulating lupus anticoagulant in a patient scheduled for surgery of the temporomandibular joint.
狼疮抗凝物是一种独特的止血抑制剂。据报道,其在系统性红斑狼疮患者中的发生率为5%至50%。这种抑制剂是内源性产生的,存在于多种临床状态中。本病例报告回顾了一名计划进行颞下颌关节手术的患者意外发现循环狼疮抗凝物的情况。